SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-298502
Filing Date
2019-11-22
Accepted
2019-11-22 16:02:03
Documents
18
Period of Report
2019-11-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d837967d8k.htm   iXBRL 8-K 35076
2 EX-1.1 d837967dex11.htm EX-1.1 234298
3 EX-5.1 d837967dex51.htm EX-5.1 35198
4 EX-99.1 d837967dex991.htm EX-99.1 7715
5 EX-99.2 d837967dex992.htm EX-99.2 8388
9 GRAPHIC g837967g12n42.jpg GRAPHIC 2014
10 GRAPHIC g837967snap0002.jpg GRAPHIC 3609
  Complete submission text file 0001193125-19-298502.txt   520621

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA crsp-20191119.xsd EX-101.SCH 3071
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20191119_lab.xml EX-101.LAB 17307
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20191119_pre.xml EX-101.PRE 10930
17 EXTRACTED XBRL INSTANCE DOCUMENT d837967d8k_htm.xml XML 3268
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 191241477
SIC: 2836 Biological Products, (No Diagnostic Substances)